112
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Optimization of radioimmunotherapy interactions with hyperthermia

, , &
Pages 190-200 | Received 17 Apr 2003, Accepted 18 Jul 2003, Published online: 09 Jul 2009

References

  • Juweid ME. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med 2002; 43: 1507–29.
  • Imam SK. Status of radioimmunotherapy in the new millennium. Cancer Biot her Radiopharrn 2001; 16: 237–56.
  • Breiz HB, Weiden PL. Radioimmunotherapy of solid tumors. In: Abrams PG, Fritzberg AR, eds, Radioimmunotherapy of Cancer, New York: Marcel Dekker, 2000: 265–306.
  • Shulz KR, Badger CC, Dombi GW, Greenberg PD, Bernstein ID. Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma. J Natl Cancer Inst 1992; 84: 109–13.
  • Khawli LA, Miller GK, Epstein AL. Effect of seven new vasoactive immunoconjugate on the enhancement of monoclonal antibody uptake in tumors. Cancer 1994; 73: 824–31.
  • Kinuya S, Yokoyama K, Kawashima A, Hiramatsu T, Konishi S, Shuke N, Watanabe N, Takayama T, Michigishi T, Tonami N. Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of RIT in human colon cancer xenografts. J Nucl Med 2000; 41: 1244–9.
  • Kalofonos HP, Rowlinson G, Epenetos AA. Enhancement of antibody uptake in human colon xenografts following radiation. Cancer Res 1990; 50: 159–63.
  • Warhoe KA, DeNardo Si, Wolkov HB, O'Grady LF, Hellstrom I, Hellstrom KE, Milla SL, Macey DJ, Goodnight JE, DeNardo GL. Evidence for external beam irradiation enhancement of radiolabeled monoclonal antibody uptake in breast cancer. Antibod Immunoconj Radiopharrn 1992; 5: 227–35.
  • Mittal BB, Zimmer MA, Sathiaseelan V, Rosen ZST, Radosevich JA, Rademarker AW, Saini A, Pierce MC, Webber DI, Spies SM. Effects of hyperthermia and iodine-131-la-beled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice. Cancer 1992; 70: 2785–91.
  • Wilder RB, Langmuir VK, Mendonca HL, Goris M, Knox Si. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res 1993; 53: 3022–7.
  • Mittal BB, Zimmer MA, Sathiaseelan V, Benson AB, Mittal RR, Dutta S, Rosen ST, Spies SM, Mettler JM, Groch MW. Phase I/II trial of combined 1311 anti-CEA mono-clonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma. Cancer 1996; 78: 1861–70.
  • Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Clin Cancer Res 1997; 3: 63–70.
  • Kinuya S, Yokoyama K, Hiramatsu T, Tega H, Tanaka K, Konishi S, Shuke N, Aburano T, Watanabe N, Takayama T, Michigishi T, Tonami N. Combination radioimmunother-apy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts. Cancer Lett 1999; 140: 209–18.
  • Hall EJ. Radiobiology for the Radiologist, 5th edn, Philadelphia: Lippincott Williams & Wilkins, 2000.
  • Spiro Ii, McPherson S, Cook JA, Ling CC, DeGraff W, Mitchell JB. Sensitization of low-dose-rate irradiation by non-lethal hyperthermia. Radiat Res 1991; 127: 111–14.
  • Raaphorst GP, Heller DP, Bussey A, Ng CE. Thermal radiosensitization by 41°C hyperthermia during low-dose-rate irradiation in human normal and tumor cell lines. Int J Hypertherrnia 1994; 10: 263–70.
  • Raaphorst GP, Bussey A, Heller DP, Ng CE. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiat Res 1995; 137: 338–45.
  • Sakurai H, Mitsuhashi N, Takahashi T, Hashida I, Niibe H. Enhanced cytotoxicity in combination of low dose-rate irradiation with hyperthermia in vitro. Int .1 Hypertherrnia 1996; 12: 355–66.
  • Dyke PW, Bradwell AR, Chapman CE, Vaughan ATM. Radioimmunotherapy of cancer: clinical studies and limiting factors. Cancer Treat Rev 1984; 14: 87–106.
  • Eddy HA. Alterations in tumor microvasculature during hyperthermia. Radiology 1980; 137: 515–21.
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res; 4 (Suppl.): 4721s–30s.
  • Leunig M, Goetz AE, Dellian M, Zetterer G, Gamarra F, Jain JK, Messmer K. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeu-tic response. Cancer Res 1992; 52: 487–90.
  • Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52: 5110–14.
  • Netti PA, Baxter LT, Boucher Y, Skalak R, Jain RK. Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res 1995; 55: 5451–8.
  • Van Bree C, Krooshoop II, Rietbroek RC, Bakker PJ. Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor. Cancer Res 1996; 56: 563–8.
  • Davies C de L, Rofstad EK, Lindmo T. Hyperthermia-induced changes in antigen expression on human FME melanoma cells. Cancer Res 1985; 45: 4109–14.
  • Wong JYC, Mivechi NF, Paxton RJ, Williams L, Beatty BG, Beatty JD, Shively JE. The effects of hyperthermia on tumor carcinoembryonic antigen expression. Int J Radiat Oncol Biol Phys 1989; 17: 803–8.
  • Philben VJ, Jakowatz JG, Beatty BG, Vlahos WG, Paxton RJ, Williams LE, Shiveley JE, Beatty JD. The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody. Cancer 1986; 57: 571–6.
  • Rostock RA, Klein JL, Leichner PK, Order SE. Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma. Int J Radiat Oncol Biol Phys 1984; 10: 1135–41.
  • Capone PM, Papsidero LD, Chu TM. Relationship between antigen density and immunotherapy response elicited by monoclonal antibodies against solid tumors. J Natl Cancer Inst 1984; 72: 673–7.
  • Johnstone RW, Andrew SM, Hogarth MP, Pietersz GA, McKenzie IFC. The effect of temperature on the binding kinetics and equilibrium constants of monoclonal antibodies to cell surface antigens. Mol Immunol 1990; 27: 327–33.
  • Hauck ML, Dewhirst MW, Zalutsky MR. The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody. Nucl Med Biol 1996; 23: 551–7.
  • Hauck ML, Zalutsky MR. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody. Clin Cancer Res 1998; 4: 2071–7.
  • Matusmoto Y, Suzuki N, Sakai K, Morimatsu A, Hirano K, Murofushi H. A possible mechanism for hyperthermic radiosensitization mediated through hyperthermic lability of Ku subunits in DNA-dependent protein kinase. Biochern Biophys Res Contrnun 1997; 234: 568–72.
  • Woudstra EC, Konings AW, Jeggo PA, Kampinga HR. Role of DNA-PK subunits in radiosensitization by hyperthermia. Radiat Res 1999; 152: 214–8.
  • Bradbury CM, Locke JE, Wei Si, Rene LM, Karimpour S, Hunt C, Spitz DR, Gius D. Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hydrogen peroxide, and cisplatin are inhibited by indomethacin in oxidative stress-resistant cells. Cancer Res 2001; 61: 3486–92.
  • Zhu WG, Seno JD, Beck BD, Dynlacht JR. Translocation of MREll from the nucleus to the cytoplasm as a mechanism of radiosensitization by heat. Radiat Res 2001; 156: 95–102.
  • Zeng Z-C, Jiang G-L, Wang G-M, Tang ZY, Curran WJ, Maids G. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World J Gastroenterol 2002; 8: 797–803.
  • Xu M, Myerson RJ, Straube WL, Moros, EG, Lagroye I, Wang LL, Lee JT, Roti Roti JL. Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. Int J Hyperthermia 2002; 18: 385–403.
  • Hauck ML, Larsen RH, Zalutsky MR. Cytotoxicity of a-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia. Br J Cancer 1998; 77: 753–9.
  • Cope BA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Enhanced delivery of a monoclonal antibody F(abi)2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 1990; 50: 1803–9.
  • Gridley DS, Ewart KL, Cao JD, Stickney DR. Hyperthermia enhances localization of 11n-labeled hapten to bifunctional antibody in human colon tumor xenografts. Cancer Res 1991; 51: 1515–20.
  • Schuster JM, Zalutsky MR, Noska MA, Dodge R, Friedman HS, Bigner DD, Dewhirst MW. Hyperthermic modulation of radiolabeled antibody uptake in a human glioma xenografts and normal tissues. Int J Hypertherrnia 1995; 11: 59–72.
  • Kinuya S, Yokoyama K, Hiramatsu T, Konishi S, Watanabe N, Shuke N, Aburano T, Bunko H, Michigishi T, Tonami N. Optimal timing of administration of hyperthermia in combined radioimmunotherapy. Cancer Biother Radiopharrn 2000; 15: 373–9.
  • Iwata K, Shakil A, Hur W-J, Makepeace CM, Griffin RJ, Song CW. Tumour p02 can be increased markedly by mild hyperthermia. Br J Cancer 1996; 74: s217–21.
  • Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyper-thermia at mild temperatures. Int J Hypertherrnia 1996; 12: 367–73.
  • Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft does not affect tumour interstitial fluid pressure. Int J Hypertherrnia 1997; 13: 307–16.
  • Saga T, Sakahara H, Nakamoto K, Sato N, Ishimori T, Mamede M, Kobayashi H, Masunaga S, Sasai K, Kuroki M, Konishi J. Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia. Eur J Cancer 2001; 37: 1429–34.
  • Masunaga S, Ono K, Akaboshi M, Nishimura Y, Suzuki M, Kinashi Y, Takagaki M, Hiraoka M, Abe M. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Br J Cancer 1997; 76: 588–93.
  • Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. Eur J Cancer 1998; 177: 137–47.
  • Kinuya S, Yokoyama K, Konishi S, Hiramatsu T, Watanabe N, Shuke N, Aburano T, Takayama T, Michigishi T, Tonami N. Enhanced efficacy of radioimmunotherapy com-bined with systemic chemotherapy and local hyperthermia in xenografted model. Jpn J Cancer Res 2000; 91: 573–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.